YAHOO FINANCE CHARTBOOK

44 charts that explain markets and the economy right now

Frankfurt - Delayed Quote EUR

Hikma Pharmaceuticals PLC (H5P.F)

26.60

+1.20

+(4.72%)

At close: 9:50:00 PM GMT+1

No Tool

Measure

UNDO

Redo

All

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for H5P.F

Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg

Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg

Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?

Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?

Hikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?

Hikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?

Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 95% Above Its Share Price

Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 95% Above Its Share Price

Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

With 55% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing

With 55% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing

Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 17% loss from investing in the stock three years ago

Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 17% loss from investing in the stock three years ago

Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day

Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day

KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months

KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months

We Think Hikma Pharmaceuticals' (LON:HIK) Robust Earnings Are Conservative

We Think Hikma Pharmaceuticals' (LON:HIK) Robust Earnings Are Conservative

Hikma Pharmaceuticals (HKMPF) Upgraded to Buy: Here's What You Should Know

Hikma Pharmaceuticals (HKMPF) Upgraded to Buy: Here's What You Should Know